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Edited by Vladimir SkulachevAbstract Reactive oxygen species (ROS) were generated in all
oxygen-utilizing organisms. Peroxiredoxin II (Prx II) as one of
antioxidant enzymes may play a protective role against the oxi-
dative damage caused by ROS. In order to deﬁne the role of Prx
II in organismal aging, we evaluated cellular senescence in Prx
II/ mouse embryonic ﬁbroblast (MEF). As compared to wild
type MEF, cellular senescence was accelerated in Prx II/
MEF. Senescence-associated (SA)-b-galactosidase (Gal)-posi-
tive cell formation was about 30% higher in Prx II/ MEF.
N-Acetyl-L-cysteine (NAC) treatment attenuated SA-b-Gal-posi-
tive cell formation. Prx II/ MEF exhibited the higher G2/M
(41%) and lower S (1.6%) phase cells as compared to 24% and
7.4% in wild type MEF, respectively. A high increase in the
p16 and a slight increase in the p21 and p53 levels were detected
in PrxII/ MEF cells. The cellular senescence of Prx II/
MEF was correlated with the organismal aging of Prx II/
mouse skin. While extracellular signal-regulated kinase (ERK)
and p38 activation was detected in Prx II/ MEF, ERK and
c-Jun N-terminal kinase (JNK) activation was detected in Prx
II/ skin. These results suggest that Prx II may function as
an enzymatic antioxidant to prevent cellular senescence and skin
aging.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cellular senescence is deﬁned as the process of cell cycle
which accompanies the exhaustion of replicative potential [1].
Senescent cells remain metabolically active, display character-
istic changes in cell morphology, physiology, and gene expres-
sion and typically exhibit an upregulation in the activity of
senescence-associated (SA)-b-galactosidase (Gal) [2–4]. Senes-Abbreviations: Prx II, peroxiredoxin II; ROS, reactive oxygen species;
MEF, mouse embryonic ﬁbroblast; SA-b-Gal, senescence-associated-
b-glactosidase; NAC, N-acetyl-L-cysteine; ERK, extracellular signal-
regulated kinase; JNK, c-Jun N-terminal kinase
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doi:10.1016/j.febslet.2005.07.049cent cells are unable to express genes required for proliferation
but express late G1 genes due to repression of E2F-1, leading
to a deﬁciency of E2F activity [5,6].
Although cellular senescence is typically studied with cul-
tured cells, the process may also be important in aging and
cancer [2,7]. Cellular senescence is often considered to be a cel-
lular counterpart of organismal aging and, indeed, increases in
SA-b-Gal activity can be detected in cells from older individu-
als. Due principally to its anti-proliferative eﬀects, senescence
also appears to be a potent antitumor mechanism. Hence,
mutation in certain tumor suppressor genes can compromise
the senescence process, thereby contributing to cell immortal-
ization and cancer [2,7].
It has been established that reactive oxygen species (ROS)
can induce cellular senescence, and senescent cells are known
to have higher levels of ROS than normal cells [8,9]. ROS is
reduced by enzymatic antioxidants such as glutathione, cata-
lase, thioredoxins, and peroxiredoxins. Superoxide dismutase
1 (SOD1) knock-down induces senescence in human ﬁbro-
blasts [10], and Gpx1/ MEF display senescent-like features
[11]. However, the role of peroxiredoxin as an enzymatic anti-
oxidant in cellular senescence remains poorly understood.
Peroxiredoxins (Prxs) can be regulated by changes in phos-
phorylation, redox and possibly the oligomerization states.
Three classes of Prxs have been identiﬁed: typical 2-Cys Prxs,
atypical 2-Cys Prxs, and 1-Cys Prxs. All Prxs share the same
basic catalytic mechanism in which the active-site cysteine
(the peroxidatic cysteine) is oxidized to sulfenic acid by perox-
ide, as a substrate [12]. This maintains the resting level of
hydrogen peroxide at a low level, while permitting higher levels
to develop during signal transduction [13,14]. These Prx family
members are distributed in the cytosol, mitochondria, peroxi-
somes and plasma, all of which comprise the sites of ROS pro-
duction. An abundance of evidences suggests that each Prx
plays various functions in a lot of biological processes includ-
ing cell proliferation, diﬀerentiation, gene expression, RBC
life-span, thymus involution, Downs syndrome and others
[15–20]. However, the function of peroxiredoxin, in particular,
peroxiredoxin II (Prx II), in cellular senescence and organismal
aging has remained mysterious.
In these studies, we attempt to determine the function of Prx
II with regard to cellular senescence using Prx II/ mouse
embryonic ﬁbroblasts (MEF). We demonstrate that X-Gal-
reactive senescence cells are vigorously formed in Prx II/
MEF cells, as compared to wild type cells at the same passage
of cultures. The higher senescence rates of the Prx II/ MEFblished by Elsevier B.V. All rights reserved.
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observe the histopathologic decrease of dermis collagen and
the biochemical activation of age-related kinase in the Prx
II/ mouse samples. Our data suggest that Prx II may play
a role to protect cellular senescence and the skin aging process.2. Materials and methods
2.1. Mice and chemicals
Wild type and PrxII-deﬁcient mice with 129/SvJ background were
maintained in the pathogen-free authorized facility in Korea Research
Institute of Bioscience and Biotechnology (KRIBB) where the temper-
ature at 20–22 C, the humidity 50–60% and the 12-h-dark/light cycles
were maintained. All animal procedures were conducted in accordance
with the guidelines of the institutional Animal Care and Use Commit-
tee, KRIBB. The genotyping of animals was performed as described
[16]. PD98059 and SB203580 were purchased from Calbiochem (La
Jolla, CA, USA). Unless indicated, chemicals were purchased from
Sigma Chemical Company (St. Louis, MI).2.2. Preparation of the MEF
MEF cells were prepared with 13.5-day embryos derived from Prx
II+/ mice mated each other. Head, tail and viscera were removed,
the remain body was minced and dispersed in 0.25% trypsin/ EDTA
and incubated in a 5% CO2 at 37 C for 30 min. Then, the large frag-
ments were removed and the cell suspension was plated in 10 cm plates
and incubated at 37 C until conﬂuent.
2.3. Cell culture
MEF cells were maintained in Dulbeccos modiﬁed Eagle medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), L-gluta-
mine and penicillin/streptomycin. The cells were incubated in a 5%
CO2 at 37 C. When the cells were plated for 4 h, various concentra-
tions of H2O2 were added to the cultures for appropriate time or the
cells were cultured with 0.5%, 3% and 10% of FBS concentrations
for appropriate days. For the inhibition of p38 and extracellular sig-
nal-regulated kinase (ERK) activity, MEF cells were treated with
5 lM PD98059 and 2 lM SB203580, respectively.2.4. SA-b-Gal staining
Cells were washed with PBS (pH 7.2–7.4) and ﬁxed with 0.5% glutar-
aldehyde in PBS for 5 min at room temperature. Then, cells were
washed twice with PBS and incubated at 37 C (no CO2) with fresh
SA-b-Gal staining solution [1 mM/ml X-Gal, 5 mM potassium ferricy-
anide, 5 mM potassium ferrocyanide, 40 mM sodium phosphate
(12.0% Na2HPO4 and 88.0% NaH2PO4, pH 6.0), 150 mM NaCl,
2 mM MgCl2] [3]. Staining was evident in 2–4 h and maximal in 12–
16 h. SA-b-Gal-positive cells were detected and counted by light
microscopy.
2.5. Flow cytometry analyses
For the determination of cell cycle and hypodiploid cell formation,
cells were ﬁxed in 40% ethanol on ice for 30 min and then incubated
with propidium iodide (50 lg/ml) and RNase (25 lg/ml) at 37 C for
30 min. Cells were analyzed by CELLQueste software in FACScali-
bure (Becton Dickinson, San Jose, CA).
2.6. Western blot analysis
Cells were lysed in ice-cold lysis buﬀer containing 0.5% Nonidet P-40
(vol/vol) in 20 mM Tris–HCl (pH 8.3); 150 mM NaCl; protease inhibi-
tors (2 lg/ml aprotinin, pepstatin, and chymostatin); 1 lg/ml leupeptin
and pepstatin; 1 mM phenylmethyl sulfonyl ﬂuoride (PMSF); and
1 mMNa4VO3. Lysates were incubated for 30 min on ice before centri-
fugationat 14000 rpmfor 5 minat 4 C.Proteins in the supernatantwere
denatured by boiling for 5 min in SDS sample buﬀer. Proteins were sep-
arated by 12% sodium dodecyl sulfate–polyacrylamide gel electrophore-
sis (SDS–PAGE), transferred to nitrocellulose membranes. Following
transfer, equal loading of protein was veriﬁed by Ponceau staining.
The membranes were blocked with 5% skim milk in Tris-buﬀered salinewith Tween 20 (TBST) (10 mM Tris–HCl, pH 7.6; 150 mMNaCl; 0.5%
Tween 20) and incubated with the indicated antibodies, polyclonal Prx I
(1:5000), Prx II (1:5000), Prx III (1:10000), Prx IV (1:5000), Prx V
(1:5000), Prx VI (1:5000), Bcl-2 (1:1000), cyclin A (1:1000), cyclin B1
(1:1000), PCNA (1:1000), p38 (1:5000), involucrin (1:1000), loricrin
(1:1000), phospho-p38 (1:1000), c-Jun N-terminal kinase (JNK)
(1:1000), phospho-JNK (1:1000), ERK (1:1000), phosphor-ERK
(1:1000), andmonoclonal tubulin (1:5000). Bound antibodies were visu-
alized with HRP-conjugated secondary antibodies with the use of
enhanced chemiluminescence (ECL) (Pierce, Rockford, IL).
2.7. Histopathological diagnoses
Skin samples were ﬁxed in 10% neutral buﬀered formalin, embedded
in paraﬃn, sectioned, and stained with hematoxylin/eosin according to
standard methods.
2.8. Statistical analyses
Experimental diﬀerences were tested for statistical signiﬁcance using
ANOVA and Students t test. P value of <0.05 was considered to be
signiﬁcant.3. Result
3.1. Cellular senescence is enhanced by the deletion of Prx II
gene
Prx II gene-deleted mice were generated by gene recombina-
tion technology and MEF cells prepared from Prx II/ mice
did not express Prx II (Supplement data 1A). The intracellular
ROS level was higher in the Prx II/ MEF cells than in the
wild type cells (data not shown). We prepared MEF cells with
13.5-day embryos. Following each MEF passage of 4–24 h
incubation, cellular senescence was assessed by measuring
SA-b-Gal activity with a substrate, X-Gal. The result of this
evaluation indicated that the number of SA-b-Gal-positive
cells was higher in the Prx II/ MEF than in the wild type.
In comparison with the wild type, the number of SA-b-Gal-
positive cells increased by the deletion of Prx II from the 4th
passage to the 14th (Fig. 1A). While this increase of SA-b-
Gal-positive cells was progressive in the wild type MEF, it
was dramatic in the Prx II/ MEF. It demonstrates that
MEF cells senesce at a higher rate as the result of oxidative stress
induced by the deletion of the enzymatic antioxidant Prx II
gene. Both types of MEF grew well in the 1st–3rd passages,
and no changes were detected in the SA-b-Gal-positive cells.
However, the SA-b-Gal-positive cells appeared in the beginning
on the 4th passage and increased slowly from the 4th to the 7th
passages. Only minor changes in the SA-b-Gal-positive cells
were noted in the 8th–14th passages. Our data suggest that
Prx II/MEF, due to the relatively high levels of ROS were rel-
atively sensitive to the culture stress and the cellular senescence.
3.2. Prx II/MEF cells were arrested at G2/M and grew slower
than wild type
We examined MEF cell growth under the diﬀerent concen-
trations of FBS. MEF cells were maintained at the exponential
growing state. Increases in cell density developed more slowly
in the Prx II/ MEF cells than in the wild type (Supplement
data 1B). In order to determine whether cell growth changed
by the deletion of the Prx II gene was related to the cell cycle
arrest, we stained the MEF cells with propidium iodide at the
7th passage. The G0/ G1, S and G2/M phase rate were 49.7%,
7.4% and 24.2%, respectively, and 42.6%, 1.6% and 41.0%,
respectively, for Prx II/ MEF. In addition, apoptosis rate
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Fig. 2. SA-b-Gal-positive cell formation was reduced by NAC
treatment. SA-b-Gal activity was detected by the incubation with X-
Gal. MEF cells at the 3rd passage were treated NAC and SA-b-Gal-
positive cells were measured as described in Section 2. All data were
mean of three experiments. *P < 0.05; **P < 0.01; signiﬁcant as
compared to NAC non-treated control at each day.
Fig. 1. Cellular senescence was enhanced by the deletion of Prx II
gene. (A) MEF cells were prepared and SA-b-Gal-positive cells were
measured from the 2nd to 14th passage. Cells were cultured for 4–24 h
prior to examining SA-b-Gal activity. Data were mean of three
independent MEF clones. Cellular senescence was enhanced by the
deletion of Prx II gene. *P < 0.05; signiﬁcant as compared to wild type
control at each passage. (B) MEF cells at the 7th passage were ﬁxed
and then incubated with propidium iodide (50 lg/ml). Cells were
analyzed by CELLQueste software in FACScalibure. Prx II/MEF
cells were arrested at G2/M. (C) Various molecular changes were
measured by Western blot analysis as described in Section 2. Numbers
under each result indicated a fold increase of band density as compared
to wild type of 3rd passage.
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II/ MEF was associated with the increased expression of
p16, p21, and p53. As compared to wild type MEF cells of
3rd passage, p16 was highly increased but a slight augmenta-
tion was detected in p21 and p53 of Prx II/MEF cells, which
resulted in the prematured senescence of PrxII/ MEF
(Fig. 1C). Our data suggest that the retardation of cell growthin the Prx II/ MEF was due to the arrest of the cell cycle at
the G2/M phase.
3.3. Serum deprivation, H2O2 and NAC treatment
From the increase of cellular senescence in the Prx II/
MEF, it can be surmised that ROS regulated by Prx II may
be a very useful cause of cellular senescence. In order to char-
acterize the eﬀects of ROS on cellular senescence, 15 lM of
H2O2 was exogenously added to the MEF cultures of the 3rd
passage, which did not show senescent cells with 4–24 h incu-
bation. SA-b-Gal-positive MEF cells began to appear 3 days
after the treatment with H2O2 and their numbers increased
gradually for 7 days (Supplement data 2A). We used IMR-
90 cells as a control model, which had previously been assessed
with regard to their cellular senescence characteristics [21]. SA-
b-Gal-positive IMR-90 cells were dose-dependently enhanced
by the addition of H2O2 3 days after H2O2 treatment. The cel-
lular senescence pattern of the IMR-90 cells was similar to the
MEF of the 3rd passage (data not shown).
In order to conﬁrm the eﬀects of H2O2 on the cellular senes-
cence of MEF, cells were cultured in the presence of low per-
centage of serum by which ROS can be produced. With 10%
serum, the morphology of either wild type or Prx II/ MEF
cells was normal, but with 3% or 0.5% serum concentrations,
abnormal morphology was noted (data not shown). After 5
days of incubation, while the number of SA-b-Gal-positive
cells increased in the presence of 10% culture condition, they
were attenuated at FBS concentrations of 3% or 0.5% FBS
(Supplement data 2B). These results suggest that endogenous
ROS in Prx II/ MEF are enough to induce senescence and
ROS amount produced in serum-starved condition was over
a limit of senescence induction. This implicates that Prx II
could play an important role to regulate cellular senescence.
SA-b-Gal-positive cell formation was attenuated by the
addition of 5 mM N-acetyl-L-cystein (NAC) for 4-day-cultures
(Fig. 2). NAC is a well-known ROS scavenger [22]. We ob-
served that the cellular morphology of the NAC-treated
MEF cells began to look better than the non-treated MEF
(data not shown). The inhibitory percentage of cellular senes-
cence associated with NAC was more signiﬁcant in the Prx
II/ MEF than in wild type. Our data suggest that the higher
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iated, in part, by ROS.
3.4. Cellular senescence is accompanied by the changes of
various molecules
In order to determine which, if any, molecules were related
to senescence in the Prx II gene-deleted samples, we performed
Western blot analyses. Based on the fact that 6 isotypes of Prxs
exist, we investigated their compensatory expression between
Prxs. No compensation was detected between Prxs, with the
exception of PrxV (Supplement data 3A). However, the func-
tion of PrxV in cellular senescence has yet to be elucidated.
We evaluated the phosphorylation of senescence-related ki-
nases, including p38, JNK and ERK. Fig. 3A shows that
p38 phosphorylation in the Prx II/MEF occurred beginning
in the 3rd passage. This is earlier than the wild type, which be-
gan to be phosphorylated from 5th passage. ERK phosphory-
lation was detected at the same passage of MEF, but its
intensity in the Prx II/ MEF was higher than in the wild
type. The phosphorylation of p38 and ERK increased gradu-Fig. 3. SA-b-Gal-positive cell formation was decreased by kinase
inhibitors. (A) MEF cell lysates were prepared from wild type (WT) or
Prx II/ MEF cells at the 3rd, 5th, 7th, and 9th passage. Following
passages, phosphorylation of senescence-related kinases, including
p38, JNK and ERK was detected by Western blot analysis. Phos-
phorylation of ERK and p38 was increased in Prx II/ MEF cells as
compared to wild type (WT) cells. (B) MEF cells were treated with p38
inhibitor, SB203580 (5 lM) or ERK inhibitor, PD98059 (2 lM) for 7
days. SA-b-Gal-positive cells were measured as described in Section 2.
*P < 0.05; **P < 0.01; signiﬁcant as compared to SB203580 or
PD98059 non-treated control in wild type and Prx II/ MEF cells.ally, and it was maintained until the 9th passage. By way of
contrast, JNK phosphorylation did not change in either wild
type or Prx II/ MEF. ERK and p38 activation was reduced
by the treatment of their inhibitors, PD98059 and SB203580,
respectively (Supplement data 3B). SA-b-Gal-positive cell for-
mation was also attenuated by the treatment of PD98059 and
SB203580 (Fig. 3B). Our data suggest that the increase in cel-
lular senescence in the Prx II/ MEF was mediated by p38
and ERK activation.
3.5. Aging is accelerated by the deletion of Prx II gene
In order to determine the eﬀects of Prx II in the whole body
aging process, we collected mouse skin samples from wild type
and Prx II/ mice. By staining paraﬃn-embedded skin with
hematoxylin/eosin, we observed that the epidermis and the der-
mis containing collagen became thinner in the Prx II/ skin
than in the wild type (Supplement data 4A). Prx II was not ex-
pressed in Prx II/ skin and the diﬀerentiation markers, such
as involucrin and loricrin of keratinocytes in epidermis were
expressed at a higher level in the Prx II/ skin (Supplement
data 4B). This suggests that Prx II may play a role in the pro-
tection of skin from organismal aging in the entire body, which
is consistent with MEF senescence.
As cellular senescence accompanies cell cycle arrest, and
senescent cells are metabolically active but do not grow, the
expression of various related molecules was examined in the
skin (Supplement data 4C). Bcl-2 levels were high in the Prx
II/ skin. Anti-apoptosis is implicated in the long-term sur-
vival of senescent cells. Cyclin A and B, which regulate G2/
M phase in the cell cycle, were expressed abundantly in the
Prx II/ skin, as compared to wild type. These ﬁndings are
consistent with the higher rate of G2/M and cellular senescence
in the Prx II/ MEF following passages. Conversely, the
expression of PCNA, which regulates cell proliferation, was in-
versely expressed in the Prx II/ skin.
We also assessed changes in the activity of various kinases,
p38, JNK and ERK. Unexpectedly, no changes in p38 phos-
phorylation were detected in Prx II/ skin. Instead, we found
that ERK and JNK phosphorylation were higher in the PrxFig. 4. Aging was accelerated by the deletion of Prx II gene. Skin
samples were taken from wild type (WT) or Prx II/ mice. Tissue
lyates were separated by Western blot for the detection of senescence-
related kinases including p38, ERK, and JNK as described in Section 2.
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phosphorylation increase in the Prx II/ MEF was similar
to that seen in the PrxII/ skin. It is thought that cellular
senescence is, in large part, reﬂected in skin aging through
ERK activation.4. Discussion
Cellular senescence is often considered to be a cellular coun-
terpart of organismal aging. While the senescence of MEF cells
was induced by high oxygen concentrations [23], this was not a
well-researched phenomenon, with the notable exceptional
study that SOD1 orGpx1 protects cells from cellular senescence
[10,11]. Although Heinz body formation in RBC and thymus
alteration have been reported [16,17], little is known regarding
the function of Prx II on cellular senescence. Data from the
present study show that Prx II-deletion causes cellular senes-
cence and skin aging at a higher rate than in the wild type.
Prx II/ MEF exhibits increased intracellular ROS, and a
higher percentage of G2/M phase than the wild type.
Our results suggest that ROS-induced cellular senescence is
highly dependent on what quantity of ROS is produced, and
whether the ROS eﬀect is acute or chronic. Three experimental
conditions were adopted in this work. One is serum depriva-
tion, which results in ROS production. The second is the addi-
tion of H2O2 to culture medium. The third is the deletion of
gene for Prx II. Our data indicate that the cellular senescence
of Prx II/ MEF was augmented by exogenous H2O2 treat-
ment and attenuated by NAC treatment. Serum deprivation
is one type of cellular stress, which results in the gradual pro-
duction of endogenous ROS but SA-b-Gal-positive cell forma-
tion was reduced. Data demonstrate that ROS concentrations
which are below a certain physiological limit are required for
cellular senescence. and ROS amounts over a certain limit in-
jure the cells. Therefore, ROS increases due to the deletion of
Prx II are suﬃcient to induce cellular senescence and skin
aging. This was not compensated by other Prx enzymes. So,
it appears that each Prx may act independently in cellular
senescence. Data suggests that ROS production in Prx II/
mice was slow and mild, which is diﬀerent from the eﬀect of
acute and strong ROS stress such as exogenously added
H2O2 and serum deprivation.
Apoptosis was reduced by toxic chemicals including ROS in
older age of rodent, which accelerate the possibility of DNA
mutation and cancer incidence [24]. Due principally to its
anti-proliferative eﬀects, senescence also appears to be a potent
antitumor mechanism [2,7,25]. No cancer incidence was de-
tected by Prx II-deletion for 24 months (data not shown). This
demonstrates that Prx II could be a regulator of ROS-medi-
ated apoptosis and cell cycle arrest. Cell cycle was arrested
at G2/M for Prx II/ MEF cells (Fig. 1B). G2/M phase-asso-
ciated cyclin A and B1 expression increased in Prx II/ mouse
skin (Supplement data 4B). Apoptosis decreased in Prx II/
thymocytes [17] was consistently reduced in Prx II/ MEF
and Prx II/ skin as judged by ﬂow cytometry analysis and
Bcl-2 expression, respectively. Data demonstrate that cellular
senescence and skin aging are to prevent tumor incidence
and DNA mutation in Prx II/ mice.
In addition, Prx II-deletion induced the epidermis diﬀerenti-
ation. This is a repair process like UVB irradiation [26] or a ker-
atinization for skin aging [27–29]. Both terminal diﬀerentiationand apoptosis are metabolically active processes that provoke a
series of dramatic cellular changes and ultimately lead to cell
death [27]. In our data, the higher epidermal diﬀerentiation
and the lower apoptosis in Prx II/ skin are implicated by
the increase of involucrin/loricrin and Bcl-2 expression, respec-
tively. Reduced PCNA expression demonstrates the decrease of
cell proliferation in Prx II/ skin. Increased cell cycle regula-
tor, cyclin A and B1 expression in Prx II/ skin is the reﬂection
of G2/M arrest in Prx II/ MEF cells. Previous reports dem-
onstrated that p53, p16, and a broad-acting cyclin-dependent
kinase inhibitor, p21 increased in senescent cells [2,30,31].
Therefore, it is required to study further if Prx II-deletion is
beneﬁcial for whole body or not.
In the meanwhile, the activation of signaling molecules in
cellular senescence is diﬀerent from that in skin aging. Senes-
cence of Prx II/ MEF cell accompanied the activation of
p38 and ERK. Prx II/ skin accompanied the activation of
ERK and JNK. This demonstrates that the process of cellular
senescence is not the same as skin aging in whole body. From
our results, ERK is an important common enzyme in the cel-
lular senescence and skin aging. Main interest in this ﬁeld is
when the enzyme is activated and whether the activation main-
tained or not. Data showed that ERK and p38 were activated
before the appearance of SA-b-Gal-positive cells. In addition,
their activation state in MEF cells was maintained and in-
creased following passages. Prx II-deletion accelerated this
process. It is possible for kinase activation as judged by phos-
phorylation to be a relative result of inactivation of phospha-
tase decreased by ROS [32].
In conclusion, although the mechanisms have yet to be fully
deﬁned, data indicate that Prx II is one of the major regulators
in the control of cellular senescence and organismal aging un-
der physiological conditions. These results for the ﬁrst time
suggest that Prx II may plays a role in the control of cellular
senescence, and that the function of ROS in senescence is
dependent on the expression of the Prx II enzyme.
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